Washington, D.C.’s medical marijuana market generated a record $10.6 million in sales in July, surpassing the previous monthly record of $10,404,293 set in April and bringing sales through the first seven months of 2026 to approximately $68 million.
The $10,605,830 generated in July represents a 2.2% increase from $10,381,484 in June and a 20% increase from the $8,837,848 generated in July 2025, according to a new report from the District’s Alcoholic Beverage and Cannabis Administration.
Licensed dispensaries accounted for $6,601,905 of July’s total, up slightly from $6,574,122 in June and up from $5,428,803 during the same month last year.
Cultivation center sales reached $903,955, rising from $853,615 in June and $783,403 in July 2025. Manufacturers generated $3,099,970, compared with $2,953,747 in June and $2,625,642 during the same period last year.
The number of registered D.C. resident patients continued to grow, increasing from 131,133 in June to 136,882 in July, a gain of 5,749 patients, or about 4.4%. A total of 40,863 unique patients were served by a registered dispensary during July, compared with 41,056 in June. The number of licensed retailers declined from 69 to 65.
D.C. residents made $4,147,363 in purchases during the month, up from $4,044,193 in June. Self-certified temporary patients from outside the district accounted for $2,028,311, while patients participating through reciprocity programs generated an additional $426,231.
Flower remained the largest retail product category, generating $3,342,816 from 737 pounds sold. Vape cartridges generated $1,227,111, followed by infused edibles at $790,758 and raw pre-rolls at $757,240. Tincture sales reached $93,613, while infused concentrates generated $149,284.
July’s record follows several months of strong sales for the district’s medical marijuana market. Sales reached $10.4 million in April, $10 million in May and $10.38 million in June before climbing to the new high in July.
